News from impedimed A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jun 29, 2020, 08:00 ET ImpediMed and The US Oncology Network Sign Agreement for Major Roll-Out of SOZO® Technology as Part of Lymphedema Prevention Program

ImpediMed Limited, a medical software technology company that non-invasively measures, monitors and manages fluid status and tissue composition using ...


Apr 20, 2020, 08:00 ET ImpediMed Releases Most Comprehensive Software Package for SOZO® Digital Health Platform

ImpediMed Limited, a medical software technology company that non-invasively measures, monitors and manages fluid status and tissue composition using ...


Apr 15, 2020, 08:00 ET Los Angeles County Cancer Center Embraces the Future of Cancer Care by Installing Four ImpediMed SOZO® Devices

City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases, fulfills its...


Feb 13, 2020, 08:00 ET NCCN Guidelines® for Breast Cancer Updated for Lymphedema

ImpediMed Limited (ASX.IPD), a medical software technology company that non-invasively measures, monitors and manages fluid status and tissue...


Dec 11, 2019, 16:10 ET ImpediMed Receives FDA 510(k) Clearance of SOZO® for Expanded Indication

ImpediMed Limited (ASX.IPD), a medical software technology company that non-invasively measures, monitors and manages fluid status and tissue...


Oct 23, 2019, 07:30 ET ImpediMed Announces Ambitious New Program Aimed at Ending Cancer-Related Lymphedema

ImpediMed Limited (ASX: IPD), a global provider of medical technology to non-invasively measure, monitor and manage tissue composition and fluid...


Jan 11, 2016, 12:30 ET ImpediMed Establishes Medical Advisory Board for Chronic Heart Failure

ImpediMed Limited (ASX: IPD), a global provider of medical technology to measure, monitor and manage fluid status and body composition, announced...


Jan 07, 2016, 01:51 ET ImpediMed Announces U.S. Commercial Launch of L-Dex® System for Assessment of Lymphedema in Cancer Survivors

ImpediMed Limited (ASX: IPD), a global provider of medical technology to measure, monitor and manage fluid status in patients, has announced the U.S. ...